« HHS and FDA Announce New Tools to Help Consumers Use | Main | FDA Approvals - (AFX UK Focus) 2006-11-18 04:15 GMT: Ban on silicone breast »

FDA Approvals - Ranbaxy Granted Favorable Decision by the U.S. Court of Appeals


Ranbaxy Granted Favorable Decision by the U.S. Court of Appeals Regarding Marketing Exclusivity for Simvastatin 80mg (PR Newswire via Yahoo! Finance)
Ranbaxy Laboratories Limited today announced that the U.S. Court of Appeals for the District of Columbia Circuit has affirmed an earlier District Circuit holding on Simvastatin, preserving 180-day exclusivity when patents are delisted from the FDA Orange Book.

Sonus Pharmaceuticals Announces Completion of Patient Enrollment in Phase 3 Pivotal Trial of TOCOSOL(R) Paclitaxel in (Business Wire via Yahoo! Finance)
BOTHELL, Wash.----Sonus Pharmaceuticals, Inc. today announced that it has completed enrollment in the Phase 3 pivotal trial of its lead oncology product candidate, TOCOSOL Paclitaxel, in women with metastatic breast cancer.
 

©2006 FDA-News.com. All rights reserved.